In the first half of 2026, a total of 21.3165 million cases of various types were accepted by courts across China, a year-on-year increase of 1.15%. Among these, criminal and civil/commercial cases declined year-on-year, while administrative and enforcement cases saw increase.Regarding the trial of

On June 26, the 23rd Session of the Standing Committee of the 14th National Peoples Congress adopted the newly revised Trademark Law of the Peoples Republic of China, this marks the first comprehensive revision of the Trademark Law since its enactment in 1983, over forty years ago. The articles have

The China Patent Award is the highest government award in the patent field in China and is regarded as an important reference for measuring the quality of independent innovation in various industries. Here’s a systematic review and statistical analysis of automotive industry award-winning patents fr

On June 16, 2026, under the witness of Chinese President Xi Jinping and President of Myanmar Min Aung Hlaing, Shen Changyu, Commissioner of the China National Intellectual Property Administration (CNIPA), and U Tun Ohn, Union Minister for Commerce of Myanmar, signed a Memorandum of Understanding (Mo

On June 15, 2026, Harbour BioMed Holdings Limited (hereinafter "Harbour BioMed") issued an announcement disclosing the latest ruling in its U.S. patent infringement litigation against Amgen Inc. and its subsidiary Teneobio (together, "Amgen"): a federal jury has found that Amgen willfully infringed